Aclaris Therapeutics
ACRS
ACRS
81 hedge funds and large institutions have $31.4M invested in Aclaris Therapeutics in 2019 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 29 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
81
Holders Change
-3
Holders Change %
-3.57%
% of All Funds
1.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
21
Reduced
29
Closed
17
Calls
$1K
Puts
$46K
Net Calls
-$45K
Net Calls Change
+$369K
Top Buyers
| 1 |
1
Man Group
London,
United Kingdom
|
$4.03M |
| 2 |
BC
2
Broadfin Capital
New York
|
$1.75M |
| 3 |
3
Morgan Stanley
New York
|
$1.87M |
| 4 |
4
Renaissance Technologies
New York
|
$2.13M |
| 5 |
RSCM
5
Rock Springs Capital Management
Baltimore,
Maryland
|
$3.21M |
